Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis

Total Page:16

File Type:pdf, Size:1020Kb

Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis Mycopathologia (2018) 183:21–32 https://doi.org/10.1007/s11046-017-0182-0 Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis Carsten Schwarz . Dominik Hartl . Olaf Eickmeier . Andreas Hector . Christian Benden . Isabelle Durieu . Amparo Sole . Silvia Gartner . Carlos E. Milla . Peter James Barry Received: 28 May 2017 / Accepted: 19 July 2017 / Published online: 31 July 2017 Ó Springer Science+Business Media B.V. 2017 Abstract Cystic fibrosis (CF) is a chronic lethal cause severe pneumonia requiring appropriate tar- multi-system condition; however, most of the mor- geted treatment. The most common fungi in respira- bidity and mortality is dependent on the status of the tory samples of patients with CF are Aspergillus respiratory system. Progressive respiratory decline is fumigatus, Aspergillus terreus and Scedosporium mediated by chronic infection and inflammation, species for filamentous fungi, and yeasts such as punctuated by important acute events known as Candida albicans and Candida glabrata. Therapeutic pulmonary exacerbations which can lead to acceler- strategies depend on the detected fungus and the ated decline. The main bacterial species causing underlying clinical status of the patient. The antifungal infections include Pseudomonas aeruginosa, Staphy- therapy can range from a simple monotherapy up to a lococcus aureus, Haemophilus influenzae and Achro- combination of three different drugs. Treatment mobacter xylosoxidans. In addition to bacteria, fungi course may be indicated in some patients for two are detected in a significant number of patients. The weeks and in others for up to six months, and in rare impact of fungal colonization of the airways is still not cases even longer. New antifungal drugs have been completely elucidated, but an increasing body of developed and are being tested in clinical studies evidence suggests an important role for moulds and offering the hope of therapeutic alternatives to existing yeasts. Although fungal infections are rare, fungi can C. Schwarz (&) I. Durieu Charite´ – Universita¨tsmedizin Berlin, Corporate Member Lyon University Hospital, Lyon, France of Freie Universita¨t Berlin, Humboldt-Universita¨tzu Berlin, and Berlin Institute of Health, Berlin, Germany A. Sole e-mail: [email protected] University Hospital la FE, Universitat de Valencia, Valencia, Spain D. Hartl Á A. Hector Universita¨tsklinik fu¨r Kinder-und Jugendmedizin S. Gartner (Abteilung I), Tu¨bingen, Germany Hospital Universitari Vall d’Hebron, Barcelona, Spain O. Eickmeier C. E. Milla Goethe University Children’s Hospital, Frankfurt/Main, Lucile Salter Packard Children’s Hospital, Stanford Germany University, Stanford, CA, USA C. Benden P. J. Barry Klinik fu¨r Pneumologie, Universita¨tsspital Zu¨rich, Zurich, University Hospital of South Manchester, Manchester, Switzerland UK 123 22 Mycopathologia (2018) 183:21–32 drugs. Identifying relevant risk factors and diagnostic 1. Increased sputum production. criteria for fungal colonization and infection is crucial 2. Multiple isolation of the same fungal species from to enabling an adequate prevention, diagnosis and sputum or bronchoalveolar lavage (BAL) (at least treatment. two culture-positive samples in 6 months). 3. Pulmonary infiltrate(s) on chest CT scan or X-ray. Keywords Yeasts Á Filamentous fungi Á Azoles Á 4. Treatment failure with antibiotic therapy (two and Polyenes Á Echinocandins Á Allylamines more antibiotic treatments, duration two or more weeks). 5. Unexplained lung function decline (exclusion of Introduction new CF-related diseases, e.g. diabetes mellitus). 6. Exclusion of new/other bacteria (e.g. non-tubercu- Patients with cystic fibrosis (CF) suffer from chronic lous mycobacteria or Pseudomonas aeruginosa). infections of the lung and multiple recurrent bron- 7. Exclusion of allergic bronchopulmonary chopulmonary disease exacerbations. Besides bacteria aspergillosis. such as Pseudomonas aeruginosa, some filamentous fungi such as Aspergillus spp., Scedosporium spp. and Exophiala spp. are gaining increasing importance as Antifungal Treatment Strategies cause of CF bronchopulmonary exacerbations. The prevalence of these pathogenic fungi ranges from 1.9 Aspergillus spp. to 56.7% [1, 2], and their pathogenicity may differ from that of bacteria as fungi may differ in their ability Aspergillus spp. are the most frequent colonizing to colonize the airways. Therefore, their pathogenicity fungal pathogens in patients with CF. In a recent study may be dependent on certain immunological pathways examining 25,975 sputum samples from patients with modifying patients’ susceptibility. Predisposing fac- CF, Aspergillus spp. were detected in 35% of samples tors such as defective muco-ciliary clearance, pro- (29% with A. fumigatus)[2]. The inhalation of longed antibiotic treatments, local inflammation, and Aspergillus conidia can chiefly result in two clinical the use of inhaled and systemic corticosteroids may scenarios, either Aspergillus colonization of the facilitate fungal growth in the CF lungs. airways or allergic bronchopulmonary aspergillosis The fungal biota is dominated by filamentous fungi (ABPA), but sensitization, aspergilloma and pul- such as Aspergillus fumigatus, Aspergillus terreus, monary infections may also occur. Aspergillus infec- Scedosporium apiospermum, and yeasts such as tions are treated with antifungal drugs. In contrast, the Candida albicans and Candida glabrata [1, 2]. How- mainstay of treatment of acute exacerbations of ABPA ever, rare fungi such as Exophiala dermatitidis, is corticosteroids, which may be augmented chroni- Trichosporon mycotoxinivorans and Rasamsonia cally with antifungal agents. The use of the anti-IgE argillacea can colonize the airways of CF patients, monoclonal antibody omalizumab has been reported causing significant clinical infections. Therapy can be in small case series [3–5], often with an antifungal challenging as some of the moulds are multi-drug therapy to reduce fungal burden and prevent exacer- resistant, for example Lomentospora prolificans. bations. The relatively small number of antifungal Others like A. fumigatus usually tend to be easily agents limits treatment options currently available. treatable. Nevertheless, an increasing number of One of the major concerns in patients with CF is that azole-resistant Aspergillus species have been they do not achieve adequate therapeutic levels with described in the recent years (for a review, see the usual doses and require higher doses, up to Hamprecht et al. in this special issue). In this context, 30–50% of recommended dose [6–9]. In addition, this review will address therapeutic strategies and there is a lack of prospective intervention studies. In a prevention of fungal infections in patients with CF. recently published Cochrane review, no randomized Since criteria for invasive fungal infections (pneu- controlled trials that evaluate the use of antifungal monia) in CF patients have not been defined yet, the therapies for the treatment of ABPA in CF patients following criteria for ‘‘highly probable’’ invasive pul- were found [10]. monary fungal infection were considered by the authors: 123 Mycopathologia (2018) 183:21–32 23 For Aspergillus infections, especially in invasive recommended for azole-resistant aspergillosis. Resis- infections, voriconazole is the recommended treat- tance to azoles might emerge as a new therapeutic ment according to almost all guidelines based on a challenge in several countries. Although de novo azole significant survival benefit, which is maintained in resistance occurs occasionally in patients during azole multiple real-life retrospective studies [11–13]. Until therapy, the main threat is the acquisition of resistance now, no consensus recommendations for treatment of through the environment. In this setting, the evolution Aspergillus infections specifically in the CF context of resistance is attributed to the widespread use of have been reached. Therefore, when treating Asper- azole-based fungicides [15], increasing the risk of gillus infections in CF, most clinicians will refer to the failure of antifungal treatment in patients with CF. aforementioned guidelines with voriconazole as first- In a study from Burgel et al. [16], A. fumigatus was line therapy. In addition to voriconazole, posacona- isolated from the sputum of 131/249 (52.6%) adult zole can also be recommended for Aspergillus infec- patients with CF. In this cohort, 47/131 (35.9%) tions and its use has been evaluated in severely ill patients had received previous treatment with itra- patients. In 67 non-CF patients receiving posacona- conazole. Interestingly, reduced susceptibility of A. zole therapy for at least 6 months, a response was seen fumigatus isolates to itraconazole (minimum inhibi- in 41 patients; 6 patients died, 9 had an adverse event, tory concentration or MIC [ 2 mg/L) was confirmed and 11 showed clinical and/or radiological deteriora- in 6/131 (4.6%) subjects. A further important issue tion. Therefore, at 6 months, posaconazole treatment regarding the risk of aspergillosis arises following was successful for 41 (61%) of 67 patients and failed lung transplantation. As CF is one of the most common for 26 (39%) of 67. Overall improvement at 6 months indications for lung transplantation, identifying risk was observed in 9 patients (13%). There were 41 factors for worse outcome after transplantation is evaluable patients at 12 months, of whom 2 had crucial [17, 18]. Pre-transplantation Aspergillus colo- primary posaconazole
Recommended publications
  • Oral Candidiasis: a Review
    International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 2, Issue 4, 2010 Review Article ORAL CANDIDIASIS: A REVIEW YUVRAJ SINGH DANGI1, MURARI LAL SONI1, KAMTA PRASAD NAMDEO1 Institute of Pharmaceutical Sciences, Guru Ghasidas Central University, Bilaspur (C.G.) – 49500 Email: [email protected] Received: 13 Jun 2010, Revised and Accepted: 16 July 2010 ABSTRACT Candidiasis, a common opportunistic fungal infection of the oral cavity, may be a cause of discomfort in dental patients. The article reviews common clinical types of candidiasis, its diagnosis current treatment modalities with emphasis on the role of prevention of recurrence in the susceptible dental patient. The dental hygienist can play an important role in education of patients to prevent recurrence. The frequency of invasive fungal infections (IFIs) has increased over the last decade with the rise in at‐risk populations of patients. The morbidity and mortality of IFIs are high and management of these conditions is a great challenge. With the widespread adoption of antifungal prophylaxis, the epidemiology of invasive fungal pathogens has changed. Non‐albicans Candida, non‐fumigatus Aspergillus and moulds other than Aspergillus have become increasingly recognised causes of invasive diseases. These emerging fungi are characterised by resistance or lower susceptibility to standard antifungal agents. Oral candidiasis is a common fungal infection in patients with an impaired immune system, such as those undergoing chemotherapy for cancer and patients with AIDS. It has a high morbidity amongst the latter group with approximately 85% of patients being infected at some point during the course of their illness. A major predisposing factor in HIV‐infected patients is a decreased CD4 T‐cell count.
    [Show full text]
  • Clinical Biotechnology and Microbiology ISSN: 2575-4750
    Page 47 to 49 Volume 1 • Issue 1 • 2017 Research Article Clinical Biotechnology and Microbiology ISSN: 2575-4750 Aspergillosis: A Highly Infectious Global Mycosis of Human and Animal Mahendra Pal* Narayan Consultancy on Veterinary Public Health and Microbiology, 4 Aangan, Ganesh Dairy Road, Anand-388001, India *Corresponding Author: Mahendra Pal, Narayan Consultancy on Veterinary Public Health and Microbiology, 4 Aangan, Ganesh Dairy Road, Anand-388001, India. Received: June 09, 2017; Published: June 19, 2017 Abstract Aspergillosis is an important opportunistic fungal saprozoonosis of worldwide distribution. The disease is reported in humans and animals including birds, and is caused primarily by Aspergillus fumigatus, a saprobic fungus of ubiquitous distribution. It occurs in aspergillosis are re- sporadic and epidemic form causing significant morbidity and mortality. Globally, over 200,000 cases of invasive ported each year. The source of infection is exogenous and respiratory tract is the chief portal of entry of fungus. A variety of clinical aspergillosis. The pathogen can signs are observed in humans and animals. Direct demonstration of fungal agent in clinical material and its isolation in pure growth be easily isolated on APRM agar. Detailed morphology of fungus is studied in Narayan stain. Numerous antifungal drugs are used in on mycological medium is still considered the gold standard to confirm an unequivocal diagnosis of clinical practice to treat cases of aspergillosis - . Certain high risk groups should use face mask to prevent inhalation of fungal spores from immediate environment. It is recommended that “APRM medium” and “Narayan stain”, which are easy to prepare and less ex including Aspergillus pensive than other stains and media, should be routinely used in microbiology and public health laboratories for the study of fungi consequences of disease.
    [Show full text]
  • Oral Antifungals Month/Year of Review: July 2015 Date of Last
    © Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 | Fax 503-947-1119 Class Update with New Drug Evaluation: Oral Antifungals Month/Year of Review: July 2015 Date of Last Review: March 2013 New Drug: isavuconazole (a.k.a. isavunconazonium sulfate) Brand Name (Manufacturer): Cresemba™ (Astellas Pharma US, Inc.) Current Status of PDL Class: See Appendix 1. Dossier Received: Yes1 Research Questions: Is there any new evidence of effectiveness or safety for oral antifungals since the last review that would change current PDL or prior authorization recommendations? Is there evidence of superior clinical cure rates or morbidity rates for invasive aspergillosis and invasive mucormycosis for isavuconazole over currently available oral antifungals? Is there evidence of superior safety or tolerability of isavuconazole over currently available oral antifungals? • Is there evidence of superior effectiveness or safety of isavuconazole for invasive aspergillosis and invasive mucormycosis in specific subpopulations? Conclusions: There is low level evidence that griseofulvin has lower mycological cure rates and higher relapse rates than terbinafine and itraconazole for adult 1 onychomycosis.2 There is high level evidence that terbinafine has more complete cure rates than itraconazole (55% vs. 26%) for adult onychomycosis caused by dermatophyte with similar discontinuation rates for both drugs.2 There is low
    [Show full text]
  • Invasive Trichosporonosis in a Critically Ill ICU Patient: Case Report
    log bio y: O ro p c e i n M A l a c c c i e n s i l s Paradžik et al., Clin Microbiol 2015, 4:4 C Clinical Microbiology: Open Access DOI:10.4172/2327-5073.1000210 ISSN: 2327-5073 Case Report Open Access Invasive Trichosporonosis in a Critically Ill ICU Patient: Case Report Maja Tomić Paradžik1*, Josip Mihić2, Jasminka Kopić3 and Emilija Mlinarić Missoni4 1Clinical Microbiology Department, Institute for Public Health Brod-Posavina County, Slavonski Brod 2Neurosurgery section, Department of Surgery, GH, Slavonski Brod 3Department of Anesthesiology and Intensive Care, GH, Slavonski Brod 4Reference Center for Systemic Mycoses, Croatian National Institute for Public Health, Zagreb *Corresponding author: Maja Tomić Paradžik, MD, Clinical Microbiology Department Institute for Public Health Brod–Posavina County, Vladimira Nazora 2A, Slavonski Brod 35-000, Croatia, Tel: +385-35-444-051; Fax: +385-35-440-244; E-mail: [email protected] Received date: June 12, 2015; Accepted date: July 15, 2015; Published date: July 22, 2015 Copyright: © 2015 Paradžik MT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Introduction Systemic infections caused by said pathogen are, consequently, most common in patients with acute leukemia, granulocytopenia, T. asahii, a yeast from the Basidiomycetes class, is one of life- neutropenia, solid tumors, hemochromatosis, uremia and AIDS or threatening opportunistic pathogens, most prominently for undergoing corticosteroid therapy and chemotherapy [4-6,10]. granulocytopenic and immunocompromised, as well as AIDS, patients [1-5].
    [Show full text]
  • Scedosporiosis in a Combined Kidney and Liver Transplant Recipient: a Case Report of Possible Transmission from a Near-Drowning Donor
    Hindawi Publishing Corporation Case Reports in Transplantation Volume 2016, Article ID 1879529, 7 pages http://dx.doi.org/10.1155/2016/1879529 Case Report Scedosporiosis in a Combined Kidney and Liver Transplant Recipient: A Case Report of Possible Transmission from a Near-Drowning Donor Rachael Leek,1 Erika Aldag,1 Iram Nadeem,1 Vikraman Gunabushanam,1 Ajay Sahajpal,1,2 David J. Kramer,2,3 and Thomas J. Walsh4 1 Department of Abdominal Transplant, Aurora St. Luke’s Medical Center, Milwaukee, WI, USA 2University of Wisconsin School of MedicineandPublicHealth,Madison,WI53726,USA 3Department of Critical Care, Aurora St. Luke’s Medical Center, Milwaukee, WI, USA 4Weill Cornell Medicine, Cornell University and New York Presbyterian Hospital, New York, NY, USA Correspondence should be addressed to Erika Aldag; [email protected] Received 29 August 2016; Accepted 6 November 2016 Academic Editor: Graeme Forrest Copyright © 2016 Rachael Leek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Scedosporium spp. are saprobic fungi that cause serious infections in immunocompromised hosts and in near-drowning victims. Solid organ transplant recipients are at increased risk of scedosporiosis as they require aggressive immunosuppression to prevent allograft rejection. We present a case of disseminated Scedosporium apiospermum infection occurring in the recipient of a combined kidney and liver transplantation whose organs were donated by a near-drowning victim and review the literature of scedosporiosis in solid organ transplantation. 1. Introduction near-drowning events. There are few cases of donor to recipient transmission of infection of Scedosporium spp.
    [Show full text]
  • Case Report Pneumocystis Carinii and Trichosporon Beigelii
    Case Report Pneumocystis Carinii and Trichosporon Beigelii Pneumonia following Allogeneic Haemopoeitic Stem Cell Transplantation Shahid Raza1, Parvez Ahmed1, Badshah Khan1, Khalilullah Hashmi1, Sajjad Mirza2, Shahid Ahmed Abbasi2, Masood Anwar2, Iftikhar Hussain3, Chaudhry Altaf2, Muhammad Khalid Kamal1 Armed Forces Bone Marrow Transplant Centre1, Armed Forces Institute of Pathology2, Combined Military Hospital3, Rawalpindi. Abstract cians and adequately trained lab staff since it can be rapidly fatal if left untreated. Trichosporon beigelii is a fungus that Pneumocystis Carinii and Trichosporon beigelii is another rare cause of pneumonia in immunocompromised are opportunistic infections in immunocompromised patients.1 patients. We report a case of a young lady who underwent haemopoeitic stem cell transplantation for relapsed acute Occurrence of both pneumocystis carinii and lymphoblastic leukemia. This 25 years old female devel- Trichosporon beigelii pneumonia in a single patient has not oped fever, dry cough and rapidly progressive dyspnoea been reported in the literature. We report a case of PCP and during post transplant neutropenia and was found to be suf- Trichosporon beigelii pneumonia in a young female who fering from Pneumocystis carinii pneumonia. She was suc- underwent haemopoeitic stem cell transplant for relapsed cessfully treated with Co-trimoxazole. The patient again acute lymphoblastic leukaemia. presented with similar symptoms on day 55 post transplant. This time Trichosporon beigelii was isolated from bron- Case Report choalveolar lavage and she responded to prompt antifungal A 25 years old female was diagnosed with acute therapy. Other complications encountered during the subse- lymphoblastic leukaemia on 29 May 2001. She received quent course were extensive subcutaneous emphysema and remission induction, intensification and cranial irradiation spontaneous pneumothorax that required chest intubation as per UK ALL X protocol.
    [Show full text]
  • Pulmonary Scedosporiosis Mimicking Aspergilloma in an Immunocompetent Host: a Case Report and Review of the Literature Fasih Ur Rahman Aga Khan University
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by eCommons@AKU eCommons@AKU Department of Surgery Department of Surgery February 2016 Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature Fasih Ur Rahman Aga Khan University Muhammad Irfan Ul Haq Aga Khan University Naima Fasih Aga Khan University, [email protected] Kauser Jabeen Aga Khan University, [email protected] Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_surg Part of the Surgery Commons Recommended Citation Rahman, F., Muhammad Irfan Ul Haq, ., Fasih, N., Jabeen, K. (2016). Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature. Infection, 44(1), 127-132. Available at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/610 Infection (2016) 44:127–132 DOI 10.1007/s15010-015-0840-4 CASE REPORT Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature Fasih Ur Rahman1 · Muhammad Irfan1 · Naima Fasih2 · Kauser Jabeen2 · Hasanat Sharif3 Received: 10 December 2014 / Accepted: 31 August 2015 / Published online: 9 September 2015 © Springer-Verlag Berlin Heidelberg 2015 Abstract A case of localized lung scedosporiosis is Introduction reported here that mimicked aspergilloma in an immu- nocompetent host. Through this case the importance of Scedosporium species is an emergent fungal pathogen asso- considering Scedosporium spp. in differential diagnosis ciated with a wide range of infections ranging, from sub- of locally invasive lung infections and fungal ball is high- cutaneous mycetoma to disseminated sepsis [1]. Localized lighted.
    [Show full text]
  • A Case of Disseminated Trichosporon Beigelii Infection in a Patient with Myelodysplastic Syndrome After Chemotherapy
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central J Korean Med Sci 2001; 16: 505-8 Copyright � The Korean Academy ISSN 1011-8934 of Medical Sciences A Case of Disseminated Trichosporon beigelii Infection in a Patient with Myelodysplastic Syndrome after Chemotherapy Trichosporonosis is a potentially life-threatening infection with Trichosporon Jong-Chul Kim, Yang Soo Kim, beigelii, the causative agent of white piedra. The systemic infection by this fungus Chul-Sung Park, Jae-Myung Kang, has been most frequently described in immunocompromised hosts with neu- Baek-Nam Kim, Jun-Hee Woo, tropenia. Here, we report the first patient with disseminated infection by T. beigelii Jiso Ryu, Woo Gun Kim in Korea, acquired during a period of severe neutropenia after chemo-therapy for Department of Internal Medicine, University of Ulsan myelodysplastic syndrome. The patient recovered from the infection after an College of Medicine, Seoul, Korea early-intensified treatment with amphotericin B and a rapid neutrophil recovery. Received : 21 June 2000 The disseminated infection by T. beigelii is still rare, however, is an emerging Accepted : 14 August 2000 fatal mycosis in immunocompromised patients with severe neutropenia. Address for correspondence Jun-Hee Woo, M.D. Division of Infectious Diseases, Asan Medical Center, UUCM, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-2224-3300, Fax: +82.2-2224-6970 Key Words : Trichosporon; Immunocompromised Host; Myelodysplastic Syndromes; Amphotericin B E-mail: [email protected] INTRODUCTION showed complete clearance of the neoplastic cells and hypo- celluar marrow. The patient’s cytopenia was supported with Trichosporon beigelii is found in soil and occasionally as a part multiple transfusions of red blood cells, platelets, and plasma.
    [Show full text]
  • Fungal Infections
    FUNGAL INFECTIONS SUPERFICIAL MYCOSES DEEP MYCOSES MIXED MYCOSES • Subcutaneous mycoses : important infections • Mycologists and clinicians • Common tropical subcutaneous mycoses • Signs, symptoms, diagnostic methods, therapy • Identify the causative agent • Adequate treatment Clinical classification of Mycoses CUTANEOUS SUBCUTANEOUS OPPORTUNISTIC SYSTEMIC Superficial Chromoblastomycosis Aspergillosis Aspergillosis mycoses Sporotrichosis Candidosis Blastomycosis Tinea Mycetoma Cryptococcosis Candidosis Piedra (eumycotic) Geotrichosis Coccidioidomycosis Candidosis Phaeohyphomycosis Dermatophytosis Zygomycosis Histoplasmosis Fusariosis Cryptococcosis Trichosporonosis Geotrichosis Paracoccidioidomyc osis Zygomycosis Fusariosis Trichosporonosis Sporotrichosis • Deep / subcutaneous mycosis • Sporothrix schenckii • Saprophytic , I.P. : 8-30 days • Geographical distribution Clinical varieties (Sporotrichosis) Cutaneous • Lymphangitic or Pulmonary lymphocutaneous Renal Systemic • Fixed or endemic Bone • Mycetoma like Joint • Cellulitic Meninges Lymphangitic form (Sporotrichosis) • Commonest • Exposed sites • Dermal nodule pustule ulcer sporotrichotic chancre) (Sporotrichosis) (Sporotrichosis) • Draining lymphatic inflamed & swollen • Multiple nodules along lymphatics • New nodules - every few (Sporotrichosis) days • Thin purulent discharge • Chronic - regional lymph nodes swollen - break down • Primary lesion may heal spontaneously • General health - may not be affected (Sporotrichosis) (Sporotrichosis) Fixed/Endemic variety (Sporotrichosis) •
    [Show full text]
  • Scedosporium, Chrysosporium, Sepedonium Ve Beauveria)
    Simpozyum: Hyalen küfler ve hyalohifomikozlar (Aspergillus dışı) TEK KONİDİYUM OLUŞTURAN HYALEN KÜFLER VE İNFEKSİYONLARI (SCEDOSPORIUM, CHRYSOSPORIUM, SEPEDONIUM VE BEAUVERIA) Şaban GÜRCAN Trakya Üniversitesi Tıp Fakültesi, Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dalı, Edirne, ([email protected]) Scedosporium Scedosporium cinsinin tıpta önemli olan ve isimleri birkaç kez değiştirilmiş olan iki türü vardır: Scedosporium apiospermum ve Scedosporium prolificans (1-3). Bunlar esasen immünkompro- mize hastalarda öldürücü pulmoner veya yaygın infeksiyonlara, immünkompetan hastalarda travma, cerrahi uygulama, boğulma veya intravenöz ilaç kullanımını takiben lokalize infeksi- yonlara neden olabilen hifomiçetlerdir (4-6). İnvazif ve yaygın infeksiyonlar organ nakli, lösemi, lenfoma, sistemik lupus eritamatozus veya Crohn Hastalığı için immünsüpresif tedavi veya kortikosteroit alan hastalarda görülür (7-9). Pseudallescheria boydii’nin aseksüel formu olan S. apiospermum tüm dünyada yaygın olarak bulunur ancak olgular daha çok İspanya, Avustralya ve takiben Amerika Birleşik Devletleri’nden bildirilmiştir (6, 7, 10). Genel virulans özellikleri düşük olmasına rağmen diğer saprofitlerle kıyaslandığında Pseudallescheria/ Scedosporium göreceli yüksek virulansa sahiptir (2, 7). Pseudallescheria/Scedosporium türleri toprak, çürüyen bitki, lağım pisliği, kirli su ve çiftlik hayvanlarının gübrelerinden izole edilebilirler (2, 7). İnsanlarda ise kütanöz (miçetom, madura ayağı), solunum sistemi ve santral sinir sistemi infeksiyonları sırasıyla en
    [Show full text]
  • Scedosporium Apiospermum EUMYCETOMA SUCCESSFULLY TREATED with ORAL VORICONAZOLE: REPORT of a CASE and REVIEW of the BRAZILIAN REPORTS on SCEDOSPORIOSIS
    Rev. Inst. Med. Trop. Sao Paulo 55(2):121-123, March-April, 2013 doi: 10.1590/S0036-46652013000200010 Scedosporium apiospermum EUMYCETOMA SUCCESSFULLY TREATED WITH ORAL VORICONAZOLE: REPORT OF A CASE AND REVIEW OF THE BRAZILIAN REPORTS ON SCEDOSPORIOSIS Flávio de Mattos OLIVEIRA(1,2), Gisela UNIS(3,4), Bruno HOCHHEGGER(5) & Luiz Carlos SEVERO(2,6,7) SUMMARY We describe a case of white-grain eumycetoma caused by Scedosporium apiospermum in an immunocompetent host that was successfully treated with oral voriconazole, and we review the Brazilian reports on scedosporiosis. KEYWORDS: Scedosporium apiospermum; Pseudallescheria boydii; Scedosporiosis; Eumycetoma, Voriconazole. INTRODUCTION examination revealed a tumor-like process of the foot that had several draining sinus tracts (Fig. 1). Foot plain radiography showed widening The asexual state of the ascomycete Scedosporium apiospermum of joint spaces, periostial reaction, bone destruction, erosive changes (previously known as Monosporium apiospermum) and its sexual and demineralization (Fig. 2). An incisional skin biopsy was taken from state, Pseudallescheria apiosperma (previously Allescheria boydii, the foot over opening draining sinuses. Haematoxilin and eosin stain Petriellidium boydii and Pseudallescheria boydii), are ubiquitous demonstrated a granulomatous response on the dermis and subcutaneous saprobic fungi commonly found in temperate climates, and have been tissue containing localized abscesses with spherical white-grain recovered from water, sewage, soil, swamps, and manure2,4. Both sexual eumycetoma. Culture of a sample of the biopsy on Sabouraud glucose forms are frequently seen in human infections (scedosporiosis), both agar revealed fungal growth identified as S. apiospermum. as the cause of systemic disease in immunocompromised patients and eumycetoma in immunocompetent patients2. Eumycetoma is a chronic progressive granulomatous infection of the subcutaneous tissue.
    [Show full text]
  • Case Report Vertebral Osteomyelitis Caused by Scedosporium Apiospermum in an Immunocompetent Male: a Case Report
    Int J Clin Exp Med 2018;11(8):8672-8676 www.ijcem.com /ISSN:1940-5901/IJCEM0066200 Case Report Vertebral osteomyelitis caused by Scedosporium apiospermum in an immunocompetent male: a case report Dan Cao1,2*, Dajiang Li1,2*, Le Yu1,2, Hongxia Bi1,2, Rong Deng1,2, Lichun Wang1,2 1Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, P.R. China; 2Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, P.R. China. *Equal contribu- tors. Received September 25, 2017; Accepted April 25, 2018; Epub August 15, 2018; Published August 30, 2018 Abstract: We describe an extremely rare case in which Scedosporium apiospermum caused vertebral osteomy- elitis in an immunocompetent 47-year-old man after he nearly drowned in a pond. The patient was admitted to West China Hospital complaining of lower back pain. Computed tomography (CT) of the chest revealed a chest-wall abscess, and CT of the lumbar spine revealed destruction in the L-3, L-4, and L-5 vertebrae. S. apiospermum was cultured from a paravertabral necrotic secretion, and antifungal therapy with voriconazole was initiated. The lower back pain disappeared after antifungal treatment, and the previously elevated white blood cell count, pro-calcitonin level, and erythrocyte sedimentation rate returned to normal. Moreover, CT showed improvement in the condition of the chest wall and lumbar spine. We report this case to advise physicians that lower back pain in near-drowning victims should raise suspicion of vertebral osteomyelitis due to the ubiquitous fungus S. apiospermum. Keywords: Vertebral osteomyelitis, Scedosporium apiospermum, near-drowning, antifungal therapy Introduction Case description Scedosporium apiospermum, is the asexual A motorcycle was submerged in a pond owing form of the filamentous fungus Pseudallesche- to a traffic accident.
    [Show full text]